Page last updated: 2024-11-02

pd 98059 and Cognition Disorders

pd 98059 has been researched along with Cognition Disorders in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, M1
Masaki, T1
Hori, K1
Masuo, Y1
Miyamoto, M1
Tsubokawa, H1
Noguchi, H1
Nomura, M1
Takamatsu, K1

Other Studies

1 other study available for pd 98059 and Cognition Disorders

ArticleYear
Hippocalcin-deficient mice display a defect in cAMP response element-binding protein activation associated with impaired spatial and associative memory.
    Neuroscience, 2005, Volume: 133, Issue:2

    Topics: Animals; Association Learning; Avoidance Learning; Behavior, Animal; Blotting, Western; Brain; Cadmi

2005